Cargando…
Expression of influenza A virus-derived peptides on a rotavirus VP6-based delivery platform
Recombinant protein technology enables the engineering of modern vaccines composed of a carrier protein displaying poorly immunogenic heterologous antigens. One promising carrier is based on the rotavirus inner-capsid VP6 protein. We explored different VP6 insertion sites for the presentation of two...
Autores principales: | Gröhn, Stina, Heinimäki, Suvi, Tamminen, Kirsi, Blazevic, Vesna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567002/ https://www.ncbi.nlm.nih.gov/pubmed/33067651 http://dx.doi.org/10.1007/s00705-020-04847-5 |
Ejemplares similares
-
Fusion Protein of Rotavirus VP6 and SARS-CoV-2 Receptor Binding Domain Induces T Cell Responses
por: Tamminen, Kirsi, et al.
Publicado: (2021) -
Rotavirus VP6 Adjuvant Effect on Norovirus GII.4 Virus-Like Particle Uptake and Presentation by Bone Marrow-Derived Dendritic Cells In Vitro and In Vivo
por: Tamminen, Kirsi, et al.
Publicado: (2020) -
Rotavirus Inner Capsid VP6 Acts as an Adjuvant in Formulations with Particulate Antigens Only
por: Heinimäki, Suvi, et al.
Publicado: (2020) -
Rotavirus Recombinant VP6 Nanotubes Act as an Immunomodulator and Delivery Vehicle for Norovirus Virus-Like Particles
por: Malm, Maria, et al.
Publicado: (2016) -
Rotavirus VP6 as an Adjuvant for Bivalent Norovirus Vaccine Produced in Nicotiana benthamiana
por: Malm, Maria, et al.
Publicado: (2019)